MedPath

The Effects of Short Message Notifications on Middle-Aged Diabetic Patients

Not Applicable
Completed
Conditions
Type2 Diabetes Mellitus
Interventions
Other: Informative messages
Registration Number
NCT04733612
Lead Sponsor
Istanbul University
Brief Summary

The objective of our study was to assess awareness-raising of medication adherence (MA), physical activity (PA), fasting blood glucose (FBG), and glycated hemoglobin A (HbA1c) values by providing information on diabetes via short message (SMS) technology.

Detailed Description

The study investigates T2DM patients who have not had surgery or cardiac event in the last 3 months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10 years and oral antidiabetic therapy for at least 1 The study design is a single-blinded randomized, controlled study, and was conducted in the Diabetes Polyclinic of the Istanbul University Medical Faculty Hospital.

Patients randomly assigned to the intervention group, in addition to traditional treatment received three to four informative SMS messages per week during the 6-month period, while the control group was followed in accordance with the traditional treatment schedule.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
125
Inclusion Criteria
  • Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM) between the last 1 and 10 years
  • Being aged between 40 and 64 years old,
  • Is treated for a minimum of 1 year with at least one oral antidiabetic drug.
Exclusion Criteria
  • Clinical diagnosis of T2DM for less than 1 year or more than 10 years.
  • Those who have had surgery or a cardiac event in the last 3 months or during the investigation.
  • Those under 40 and over 64 years of age.
  • Patients with T2DM that have not been treated with oral antidiabetic medication.
  • Volunteers who once did not participate in the control examinations in both groups were excluded from the evaluation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SMS GroupInformative messagesIn addition to traditional treatment received three to four informative SMS messages per week during the 6-month period
Primary Outcome Measures
NameTimeMethod
Fasting blood glucoseBeginning

After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).

Change from Baseline Fasting blood glucose at 3 months3 months after beginning

After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).

Glycated hemoglobin A (HbA1c)Beginning

In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method.

Change from Baseline Physical Activity at 3 months3 months from beginning

The International Physical Activity Questionnaire (IPAQ) was used to evaluate the physical activity level of the participants at at 3 months after the beginning of the study.

This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.

Change from Baseline Drug Adherence at 6 months6 months after beginning

The Morisky Medication Adherence Scale (MMAS-8) was used to assess the compliance of patients with drug treatment.

If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.

Change from Baseline Quality of Life Assessed by SF-36v2 at 3 months3 months after beginning

The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.

Change from Baseline of Glycated hemoglobin A (HbA1c) at 3 months3 months after beginning

In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method

Physical Activity levelBeginning

The International Physical Activity Questionnaire (IPAQ) was used to evaluate the physical activity level of the participants at the beginning of the study.

This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.

Change from Baseline Fasting blood glucose at 6 months6 months after beginning

After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).

Change from Baseline of Glycated hemoglobin A (HbA1c) at 6 months6 months after beginning

In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method

Change from Baseline Physical Activity at 6 months6 months from beginning

The International Physical Activity Questionnaire (IPAQ) was used to evaluate the change in physical activity level of the participants at at 6 months after the beginning of the study.

This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.

Drug AdherenceBeginning

The Morisky Medication Adherence Scale (MMAS-8) was used to assess the compliance of patients with drug treatment.

If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.

Change from Baseline Drug Adherence at 3 months3 months after beginning

The Morisky Medication Adherence Scale was used to assess the compliance of patients with drug treatment.

If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.

Quality of Life Assessed by SF-36v2Beginning

The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.

Change from Baseline Quality of Life Assessed by SF-36v2 at 6 months6 months after beginning

The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.

Secondary Outcome Measures
NameTimeMethod
Baseline heart rateBeginning

The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.

Baseline blood pressureBeginning

The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.

Change from Baseline blood pressure at 3 months3 months after beginning

The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.

Change from Baseline heart rate at 3 months3 Months After Beginning

The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.

Change from Baseline Body Mass Index at 6 months6 months after Beginning

The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.

Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:

BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.

Change from Baseline blood pressure at 6 months6 months after beginning

The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.

Change from Baseline heart rate at 6 months6 Months After Beginning

The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.

Baseline body fat ratiosBeginning

The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.

Baseline Body Mass IndexBeginning

The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.

Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:

BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.

Change from Baseline Body Mass Index at 3 months3 months after Beginning

The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.

Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:

BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.

Change from Baseline Diet and Nutritional Habits at 6 months6 Months after Beginning

The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.

Change from Baseline Body Fat Ratios at 3 Months3 Months After Beginning

The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.

Change from Baseline waist/hip ratio at 3 Months3 Months after Beginning

The volunteers waist and hip circumference and waist/hip ratio were measured by tape measure after 8 hours of fasting in the morning with thin clothes on them.

Waist circumference (cm) was measured at the level of the umbilicus and hip circumference (cm) at the level of the femur trochanter major.

Waist/hip ratio (WHR) were were calculated as follows

waist/hip ratio= waist circumference / hip circumference

Baseline Energy IntakeBeginning

From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.

Change from Baseline Energy Intake at 3 months3 months after Beginning

From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.

Change from Baseline Body Fat Ratios at 6 Months6 Months After Beginning

The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.

Baseline waist/hip ratioBeginning

The volunteers waist and hip circumference and waist/hip ratio were measured by tape measure after 8 hours of fasting in the morning with thin clothes on them.

Waist circumference (cm) was measured at the level of the umbilicus and hip circumference (cm) at the level of the femur trochanter major.

Waist/hip ratio (WHR) were were calculated as follows

waist/hip ratio= waist circumference / hip circumference

Baseline Diet and Nutritional HabitsBeginning

The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.

Change from Baseline Diet and Nutritional Habits at 3 months3 Months after Beginning

The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.

Change from Baseline Energy Intake at 6 months6 months after Beginning

From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.

© Copyright 2025. All Rights Reserved by MedPath